Clinical Trial Update: Bafetinib in Treating Patients With Recurrent High-Grade Glioma or Brain Metastases [Phase 1]

View source ↗

Summary

This Phase 1 trial assessing bafetinib in adults with recurrent high-grade glioma or brain metastases has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anaplastic Astrocytoma
• Anaplastic Ependymoma
• Anaplastic Oligodendroglioma
• Brain Metastases
• Glioblastoma
• Gliosarcoma
• Oligoastrocytoma

Drugs mentioned

• bafetinib (bafetinib)

Snippet

Sponsor: City of Hope Medical Center | Conditions: Adult Anaplastic Astrocytoma, Adult Anaplastic Ependymoma | Phase 1 | Status: COMPLETED